Home / Business / High Profile Active Buzzers: Lululemon Athletica (NASDAQ:LULU), Coca-Cola European Partners (NYSE:CCE)

High Profile Active Buzzers: Lululemon Athletica (NASDAQ:LULU), Coca-Cola European Partners (NYSE:CCE)

Lululemon Athletica Inc. (NASDAQ:LULU) persists its position slightly strong in context of buying side, while shares price surged 0.09% during latest trading session. On Thursday, September 1st, Lululemon (LULU) will release its Q2 2016 earnings results. The firm is presently a Zacks Rank #3 (Hold) and shares are up about 49% year-to-date.

Dave will look into Lululemon’s past earnings, look at what is presently going on with the firm, and gives us his thoughts on their upcoming earnings announcement. Additional more, Dave will look into some potential options trades for investors looking to make a play on Lululemon ahead of earnings.

Analysts Practices; to watch unbiased undervalue securities, there is need to see following technical rations. LULU holds price to earnings ratio of 41.30 that presents much better indication for a stock’s value than the market price alone. Based on historic views, the average P/E ratio in market fluctuates between 15 to 25, but alone low P/E ratio does not necessarily mean that a company is undervalue.

Narrow down focus to other ratios, the co has current ratio of 4.80 that indicates if LULU lies in 1.3% to 3% then it is acceptable for both active and passive investors, but sometimes its varies industry to industry. Generally, it indicates good short-term financial strength. Street is more conscious on this after SunEdison, Inc. case. To make strengthen these views, the active industry firm has Quick Ratio of 3.40, which indicates firm has sufficient short-term assets to cover its immediate liabilities. In addition, the firm has debt to equity ratio of 0.00, sometimes its remain same with long term debt to equity ratio.

Following previous ticker characteristics, Coca-Cola European Partners Plc (NYSE:CCE) also run on active notice, stock price raised 0.13% after traded at $38.66 in most recent trading session.

CCE has price to earnings ratio of 15.91 and the price to current year EPS stands at -3.60%. Whereas the traders who further want to see about this, may be interested to see Price to next year’s EPS that would be 8.87%. The earning yield also gives right direction to lure investment, as the co has 3.10% dividend yield. Moving toward ratio analysis, it has current ratio of 0.90 and quick ratio was calculated as 0.80. The debt to equity ratio appeared as 4.37 for seeing its liquidity position.

Taking notice on volatility measures, price volatility of stock was 1.05% for a week and 1.35% for a month. The price volatility’s Average True Range for 14 days was 0.52. On these bases, analysts would recommend this stock as an “Active Revolving Stocks.” The firm attains analyst recommendation of 2.30 out of 1-5 scale with week’s performance of 1.07%. CCE’s institutional ownership was registered as 32.90%, while insider ownership was 3.21%.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Check Also

Stocks Showing Promising Returns on Investment- Baxter International (NYSE:BAX), Provectus Biopharmaceuticals (NYSE:PVCT)

Baxter International Inc. (NYSE:BAX) persists its position slightly strong in context of buying side, while …

Leave a Reply

Your email address will not be published. Required fields are marked *